Advisors Asset Management Inc. Purchases 25,028 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Advisors Asset Management Inc. lifted its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 337.9% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 32,435 shares of the medical device company’s stock after buying an additional 25,028 shares during the period. Advisors Asset Management Inc.’s holdings in Cooper Companies were worth $3,291,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in COO. SG Americas Securities LLC grew its stake in shares of Cooper Companies by 220.9% in the fourth quarter. SG Americas Securities LLC now owns 4,326 shares of the medical device company’s stock worth $1,637,000 after acquiring an additional 2,978 shares during the period. Raymond James & Associates lifted its position in shares of Cooper Companies by 2.3% during the fourth quarter. Raymond James & Associates now owns 143,961 shares of the medical device company’s stock valued at $54,481,000 after buying an additional 3,298 shares during the last quarter. Assenagon Asset Management S.A. boosted its stake in Cooper Companies by 207.4% in the fourth quarter. Assenagon Asset Management S.A. now owns 42,493 shares of the medical device company’s stock valued at $16,081,000 after acquiring an additional 28,669 shares in the last quarter. Altfest L J & Co. Inc. increased its holdings in shares of Cooper Companies by 22.5% during the fourth quarter. Altfest L J & Co. Inc. now owns 1,257 shares of the medical device company’s stock valued at $476,000 after acquiring an additional 231 shares in the last quarter. Finally, Blue Trust Inc. lifted its holdings in shares of Cooper Companies by 54.8% during the fourth quarter. Blue Trust Inc. now owns 96 shares of the medical device company’s stock worth $36,000 after purchasing an additional 34 shares during the period. 24.39% of the stock is currently owned by institutional investors.

Cooper Companies Stock Performance

COO traded up $0.53 during trading on Friday, hitting $93.21. The stock had a trading volume of 1,063,395 shares, compared to its average volume of 1,130,185. The Cooper Companies, Inc. has a twelve month low of $75.93 and a twelve month high of $104.07. The company’s 50-day moving average price is $91.39 and its 200 day moving average price is $94.28. The firm has a market capitalization of $18.56 billion, a P/E ratio of 54.75, a PEG ratio of 2.28 and a beta of 0.98. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.14 and a current ratio of 1.95.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Thursday, May 30th. The medical device company reported $0.85 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.83 by $0.02. The business had revenue of $942.60 million during the quarter, compared to the consensus estimate of $948.07 million. Cooper Companies had a return on equity of 8.87% and a net margin of 9.11%. The business’s revenue was up 7.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.77 EPS. On average, equities research analysts forecast that The Cooper Companies, Inc. will post 3.57 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts have weighed in on COO shares. Robert W. Baird upped their price objective on shares of Cooper Companies from $116.00 to $118.00 and gave the stock an “outperform” rating in a research report on Friday, May 31st. Piper Sandler reaffirmed an “overweight” rating and set a $115.00 target price on shares of Cooper Companies in a research note on Wednesday, July 3rd. Citigroup increased their price target on shares of Cooper Companies from $108.00 to $116.00 and gave the stock a “buy” rating in a research report on Wednesday, April 3rd. Jefferies Financial Group raised shares of Cooper Companies from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $107.00 to $115.00 in a research report on Tuesday, July 16th. Finally, Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research note on Friday, May 31st. Four research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to MarketBeat.com, Cooper Companies currently has an average rating of “Moderate Buy” and a consensus price target of $111.78.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.